cjc-1295 ipamorelin study (no DAC) + Blend (CJC-1295 / Ipamorelin): Research Blend, COA & ≥99% Purity CJC-1295 + Ipamorelin Blend 10mg
Description
Tumor-imposed metabolic restrictions can mediate T cell hyporesponsiveness during cancer
Kuboki Y, Fakih M, Strickler J, Yaeger R, Masuishi T, Kim EJ, Bestvina CM, Kopetz S , Falchook GS, Langer C, Krauss J, Puri S, Cardona P, Chan E, Varrieur T, Mukundan L, Anderson A, Tran Q, Hong DS
Always discuss with a medical professional to make an informed decision
doi: 10.1016/j.dhjo.2015.12.002
